Evidence map›Paper›PMID 31448230›Full record

ReviewFrontiers in oncology2019

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.

Irene Della Starza, Sabina Chiaretti, Maria S De Propris, Loredana Elia, Marzia Cavalli, Lucia A De Novi, Roberta Soscia, Monica Messina, Antonella Vitale, Anna Guarini and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Post-Transplant Relapse in Acute Leukemia: Comparative Value of MRD and Chimerism.Mediterranean journal of hematology and infectious diseases · 2026
    Article
  8. Novel Therapeutic Approaches in Pediatric Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Irene Della StarzaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Sabina ChiarettiHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Maria S De ProprisHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Loredana EliaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Marzia CavalliHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Lucia A De NoviHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Roberta SosciaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Monica MessinaHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Antonella VitaleHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Anna GuariniHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Robin FoàHematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute lymphoblastic leukemia (ALL)digital droplet PCR (ddPCR)flow cytometryminimal residual disease (MRD)next generation flow cytometry (NGF)next generation sequencing (NGS)novel agentsreal time quantitative PCR (RQ-PCR)

Identifiers

PMID31448230
PMCPMC6692455
OpenAlexW2964177223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.